Amanda Cray

Amanda Cray is currently the Executive Director of Investor Relations and External Communications at Autolus Therapeutics. They have extensive experience in investor relations and corporate communications, having previously held senior positions at Fusion Pharmaceuticals, Novelion Therapeutics, and Aegerion Pharmaceuticals. Their career began as an Admin at Mazonson LLC, followed by roles at Harron & Associates and Financial Dynamics, before becoming an Associate at Sharon Merrill Associates. Amanda earned a B.A. in Political Science from the University of New Hampshire and an M.S. in Corporate Public Relations from Boston University.